Table 2.
Overview of all patients in this study
| Patient | Age (years) | Sex | GMFCS | Scoliosis and/or pelvic obliquity (*previous spine surgery) | Use of skin traction | Botulinum toxin (used peri-operatively) | Pre-operative VAS | Post-operative VAS | Follow-up (months) | Complications |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 40 | F | 5 | Y | 6 | 2 | 36 | |||
| 2 | 36 | F | 4 | Y* | 5 | 1 | 37 | |||
| 3 | 16 | M | 4 | Y* | 7 | 4 | 36 | |||
| 4 | 22 | F | 5 | Y | 6 | 2 | 38 | |||
| 5 | 20 | F | 4 | Y | Y | 9 | 5 | 35 | ||
| 6 | 22 | M | 5 | Y | Y | 8 | 4 | 40 | Prolonged pain | |
| 7 | 10 | F | 4 | Y | 9 | 5 | 68 | Chest infection | ||
| 8 | 17 | F | 4 | Y | Y | 7 | 1 | 28 | Unilateral revision for proximal femoral migration | |
| 9 | 19 | F | 4 | Y* | Y | 8 | 1 | 39 | ||
| 10 | 38 | F | 4 | 9 | 2 | 28 | Superficial wound infection | |||
| 11 | 32 | F | 4 | Y | 10 | 0 | 49 | |||
| 12 | 22 | F | 5 | Y* | Y | 7 | 3 | 169 | ||
| 13 | 23 | M | 4 | Y | 7 | 3 | 123 | Constipation | ||
| 14 | 19 | M | 4 | Y | Y | Y | 9 | 3 | 157 | Prolonged pain |
| 15 | 23 | M | 4 | Y* | 10 | 2 | 27 | |||
| 16 | 26 | F | 5 | Y* | 8 | 1 | 59 | |||
| 17 | 17 | M | 5 | Y | Y | 10 | 1 | 36 | Chest infection | |
| 18 | 15 | M | 5 | Y | Y | 10 | 2 | 27 | ||
| 19 | 19 | F | 5 | 8 | 3 | 47 | ||||
| 20 | 31 | F | 5 | 9 | 1 | 54 |
GMFCS gross motor function classification scale, VAS visual analogue scale of 0–10: where 0 no pain and 10 worst pain ever experienced